What to Do When Antihistamines Stop Working for Chronic Hives: 5 Options

But even if antihistamines are working at first, they may stop working to treat chronic hives. That’s when you’ll likely need to try a different option.
“Although over-the-counter antihistamines can usually be enough to provide relief, the activity of hives can wax and wane, which means antihistamines may be more or less effective at different times,” says Dr. Weiler. “When it becomes less effective, there are other choices in stepping up treatment.”
Here are five options your doctor might recommend if your antihistamines stop working for you.
1. Blockers
When over-the-counter medications — such as cetirizine (Zyrtec Allergy), fexofenadine (Allegra Hives), levocetirizine (Xyzal Allergy 24HR), and loratadine (Claritin) — don’t work well for you, your doctor may prescribe a medication known as an H2 blocker, or H2 antihistamine.
- cimetidine
- famotidine
- nizatidine
If that type of multi-medication approach also doesn’t work for you, then you’d likely be taken off antihistamines altogether to try a different strategy, he says.
11 Skin Care Ingredients That Can Trigger Allergic Reactions
Next up video playing in 10 seconds
2. Corticosteroids
Oral corticosteroids (also called steroids or glucocorticoids) such as prednisone could be the next step if antihistamines aren’t working, Dr. Camp says.
3. Biologics
A next step in treatment is to consider biologic medications, particularly when hives become frequent or intense, and don’t respond to antihistamines or corticosteroids, says Amiirah Aujnarain, MD, an allergist, immunologist, and pediatrician at Kindercare Pediatrics in East York, Ontario, Canada.
About 30 percent of chronic hives are linked with IgE. Biologics work by binding to this antibody and reducing its effects — a process that decreases the release of histamine as well.
4. BTK Inhibitors
In September 2025, the FDA approved remibrutinib (Rhapsido) for the treatment of chronic hives in adults whose symptoms are not relieved with H1 antihistamines.
- Nasal congestion
- Sore throat
- Runny nose
- Bleeding
- Headache
- Nausea
- Abdominal pain
5. Lifestyle Changes
Those include:
- With the help of your doctor, identify and avoid any food triggers that may prompt symptoms.
- Reduce exposure to airborne allergens, like pet dander or pollen, if you are allergic.
- Use detergents and soaps without scents or dyes, which could irritate your skin.
- Avoid extreme temperature changes, which can prompt hives or worsen symptoms for some people.
- Do your best to manage stress, which doesn’t directly cause hives but can make them worse.
- Wear loose-fitting, lightweight clothing to avoid skin irritation.
These lifestyle changes can be helpful for reducing the frequency, duration, and intensity of hives. But they’re often used as an addition to medications, not as a replacement.
The Takeaway
- Over-the-counter (H1) antihistamines are nearly always the first line of treatment for a hives rash, since these meds can block histamine, a chemical in the body that prompts hives symptoms.
- Prescription antihistamines, corticosteroids, biologic medications, and BTK inhibitors are the next steps when over-the-counter options aren’t working for you.
- Some lifestyle changes may help ease hives. But they’re often used along with medication rather than in place of it.
- If you’re getting more-frequent hives, and especially if they’re becoming worse and you’re not getting relief from over-the-counter antihistamines, talk with your doctor about other options that can help.
Resources We Trust
- Mayo Clinic: Hives and Angioedema: Symptoms & Causes
- Cleveland Clinic: Hives
- American Academy of Dermatology: Hives Diagnosis and Treatment
- Asthma and Allergy Foundation of America: Hives (Urticaria)
- Allergy & Asthma Network: Hives
- Hives. Cleveland Clinic. October 14, 2022.
- Farzam K et al. Antihistamines. StatPearls. July 10, 2023.
- Antihistamines. Cleveland Clinic. July 26, 2024.
- Monroe EW et al. Combined H1 and H2 Antihistamine Therapy in Chronic Urticaria. JAMA Dermatology. July 1981.
- Corticosteroids (Glucocorticoids). Cleveland Clinic. October 21, 2024.
- Immunoglobulin E (IgE) Defined. American Academy of Allergy, Asthma, and Immunology. July 8, 2024.
- Omalizumab (Subcutaneous Route). Mayo Clinic. May 1, 2025.
- Dupixent. U.S. Food and Drug Administration. April 2025.
- Novartis Receives FDA Approval for Rhapsido (Remibrutinib), the Only Oral, Targeted BTKi Treatment for Chronic Spontaneous Urticaria (CSU). Novartis. September 30, 2025.

Asal Naderi, MD
Medical Reviewer
Asal Naderi, MD, is an assistant clinical professor of allergy and immunology at the Keck School of Medicine at the University of Southern California. Her areas of focus include allergic rhinitis, asthma, chronic sinusitis with nasal polyposis, chronic urticaria, angioedema, food allergy, drug allergy, and primary immunodeficiencies.
She received her bachelor's degree from the University of California Los Angeles and then received her medical degree from Saint Louis University. She completed her internal medicine residency at University of California Irvine, and her fellowship at the University of California Irvine. She has been a principal investigator in clinical trials for asthma as well as chronic sinusitis.
Outside of the office, she enjoys exercising, cooking and spending time with her family and friends.

Elizabeth Millard
Author
Elizabeth Millard is a Minnesota-based freelance health writer. Her work has appeared in national outlets and medical institutions including Time, Women‘s Health, Self, Runner‘s World, Prevention, and more. She is an ACE Certified Personal Trainer and a Yoga Alliance Registered Yoga Teacher, and is trained in obesity management.